AASLD: American Association for the Study of Liver Diseases
Home | Contact Us | Log In/Out
About Us | Join | Public PolicyPatients | Giving to AASLD | Career Center | News | Worksites | Related Societies
The Best of The Liver Meeting® 

Postgraduate Course 2010 
|

The Best of The Liver Meeting® lets you catch up with what you missed at the meeting and enables you to revisit a session.  All of the sessions are presented with audio and synchronized slide presentations. 

Below is a list of The Best of The Liver Meeting® 2010 Postgraduate Course sessions.

 Program Presentation  Presenter
Session 1: Viral Hepatitis: The Past, Present, and Future Moderator: T. Jake Liang, MD



Session Unavailable
History of Viral Hepatitis

Harvey J. Alter, MD

Epidemiology and Global Health Burden of Viral Hepatitis

 

John W. Ward, MD
Session 2: Hepatitis B and D: The Changing Face of the Infection and the Disease Moderators: Brian J. McMahon, MD and Norah Terrault, MD
F. Blaine Hollinger, MD

Hepatitis B: The Virus 

John Tavis, PhD

Hepatitis B: Pathogenesis and Disease 

Kyong-Mi Chang, MD

Current Therapy of Hepatitis B 

 

Steven-Huy Bui Han, MD
Drug Resistance in Antiviral Therapy of Hepatitis B

Marc G. Ghany, MD

Therapy of Hepatitis B: Unresolved Issues and Remaining Challenges 

Jay H. Hoofnagle, MD
Session Unavailable

Hepatitis D Virus: The Virus, Disease, and Therapy 

Jeffrey S. Glenn, MD, PhD
Case Presentation and Debate: Hepatitis B

Jordan J. Feld, MD, MPH and Natalie Helen Bzowej, MD, PhD


Session 3: Enteric-Transmitted Viral Hepatitis: The Unrecognized Threat Moderators: Stephen M. Feinstone, MD and Kris Krawczynski, MD, PhD




Session Unavailable Hepatitis A: The Virus and Disease

Stanley M. Lemon, MD
Hepatitis A: Epidemiology, Vaccination, and Global Control

Daniel Shouval, MD
Hepatitis E: The Virus, Disease, and Prevention


Kenneth E. Sherman, MD, PhD
Session 4: Hepatitis C Virus: The State of the Science Moderators: Hugo R. Rosen, MD and Gyongi Szabo, Md, PhD
Virology of Hepatitis C Virus

Thomas F. Baumert, MD
Immunopathogenesis of Hepatitis C

Barbara Rehermann, MD
Hepatitis C, NAFLD, and Metabolic Syndrome

Christopher P. Day, MD, PhD
Hepatitis C: Vaccine Development and Global Control


Marian E. Major, PhD
Session 5: Hepatitis C: The State of the Therapy Moderators:  Kyong-Mi Chang, MD and Adrian M. Di Bisceglie, MD


Current Therapy of Hepatitis C

David Nelson, MD
Future Therapy of Hepatitis C

Raymond T. Chung, MD
Therapy of Hepatitis C: Viral Resistance and Remaining Challenges

Jean-Michel Pawlotsky, MD, PhD
Case Presentation and Debate: Acute Hepatitis C


Ira M. Jacobson, MD and Heiner Wedemeyer, MS
Session 6: Viral Hepatitis: The Difficult Issues and Current Challenges Moderators: Joel E. Lavine, MD, PhD, John G. McHutchison, MD, William M. Lee, MD, and Anna S. F. Lok, MD


Noninvasive Markers of Fibrosis and Disease Severity in Viral Hepatitis

Jayant A. Talwalkar, MD, MPH
Viral Hepatitis and Genomic Medicine

Richard O'Brien, MD
Therapy of Viral Hepatitis in Pediatric Population

Maureen M. Jonas, MD
Viral Hepatitis and Liver Transplantation

Paul Martin, MD
Session Unavailable Viral Hepatitis and HIV Co-infection

David L. Thomas, MD
Therapy of Viral Hepatitis in Special Populations

Michael W. Fried, MD
Viral Hepatitis and Hepatocellular Carcinoma

Hashem B. El-Serag, MD
Viral Hepatitis: What Beholds the Future



Willis C. Maddrey, MD